April 2021
|
|
Washington, D.C. (Apr. 8, 2021)—Today, Rep. Stephen F. Lynch, Chairman of the Subcommittee on National Security; Rep. Gerald E. Connolly, Chairman of the Subcommittee on Government Operations; and Committee Member Rep. Katie Porter sent a letter to Secretary of Defense Lloyd J.
Washington, D.C. (April 7, 2021)—On Thursday, April 15, 2021, at 10:00 a.m. ET, Rep. James E. Clyburn, the Chairman of the Select Subcommittee on the Coronavirus Crisis, will hold a hybrid in-person / remote hearing with Centers for Disease Control and Prevention Director Rochelle P. Walensky, National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci, and Chief Science Officer for COVID Response David Kessler.
Washington, D.C. (Apr. 6, 2021)—Today, Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, sent a letter to YouTube requesting documents and information about the YouTube Kids platform amid concerns about content quality, advertisement practices, and the impact on children.
Washington, D.C. (Apr. 6, 2021)—Rep. Gerald E. Connolly, Chairman of the Subcommittee on Government Operations, and Rep. Jody B. Hice, Ranking Member of the Subcommittee on Government Operations, sent a letter to President Joseph R. Biden requesting that he prioritize nominations to the Merit Systems Protection Board (MSPB).
Washington D.C. – Today, Reps. Adam Schiff (D-CA) and Carolyn B. Maloney (D-NY), along with Reps. Barbara Lee (D-CA), Mike Quigley (D-IL), Katherine Clark (D-MA), Jamie Raskin (D-MD), Alexandria Ocasio-Cortez (D-NY), Chris Pappas (D-NH), and Ritchie Torres (D-NY) introduced a resolution highlighting the urgent need for nondiscriminatory and equitable blood and blood product donation policies in the United States.
| Washington, D.C. (Apr. 1, 2021)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued this statement following release of the Office of National Drug Control Policy's (ONDCP) Drug Control Policy Statement: "I am pleased to see the Biden-Harris Administration's ONDCP meet its first benchmark in the timely release of the required Drug Control Policy Statement, especially after the failures of the last administration.
|
WASHINGTON, D.C. — The U.S. Government Accountability Office (GAO) released a new report reviewing the government funding that led to the development of the drug Remdesivir, which costs $3,120 for a five day course of treatment.